InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,011.12
(
-0.22%
)
US TECH 100
16,884.00
(
-0.31%
)
Dow Jones
37,775.38
(
0.00%
)
Brent Oil
86.11
(
-0.36%
)
Bitcoin
64,967.86
(
2.30%
)
Post# of 251526
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: None

Thursday, 07/24/2014 5:25:37 AM

Thursday, July 24, 2014 5:25:37 AM

Post# of 251526
HALO / Roche Herceptin update: From Roche's earnings call

Herceptin Subcutaneous deliveries: Fast adoption in vast majority of countries

Herceptin SC OVER 50% of the Market in UK, Denmark, and Sweden

Herceptin SC between 40-50% of the Market in Chile, Finland, Austria, Norway

https://d3j5vwomefv46c.cloudfront.net/photos/large/861292128.jpg?1406183721

Looks like some nice royalties will start coming in. Maybe Manthera's adoption will be equally good?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up